title: PTTG overexpression is correlated with angiogenesis in human pituitary adenomas.
abstract: Human pituitary tumor transforming gene (hPTTG1) was recently identified as a protooncogene, which is a regulator of the cell cycle, as a homolog of yeast securin and a transcriptional activator of several angiogenic factors. Here we examined the relationships of hPTTG1 expression with cell proliferation, expression of the angiogenic factor, VEGF (vascular endothelial growth factor), and numbers of the blood vessels in the normal and/or adenomatous pituitary. With the exception of TSHoma, the expression of hPTTG1 was significantly higher in pituitary adenomas than in the normal pituitary gland. The cell proliferation activity was higher in pituitary adenomas than in the normal pituitary. Pituitary cell proliferation was significantly correlated with the level of hPTTG1 expression in the normal pituitary tissue, but there was no such correlation in the adenomas. The significant correlation of hPTTG1 with the VEGF expression and the numbers of the blood vessels was elucidated in pituitary adenomas. It is particularly noteworthy that immunohistochemical double staining indicated co-localization of VEGF in many hPTTG1-positive tumor cells. In conclusion, higher levels of hPTTG1 expression contribute to the pathobiology of pituitary adenomas by promoting angiogenesis rather than by activating cell proliferation, whereas hPTTG1 expression is related to mitotic activity in the normal pituitary gland.
authors.affiliation: Department of Pathology, Tokai University School of Medicine. Bohseidai, Isehara, Kanagawa 259-1193, Japan.
authors.forename: Takeo
authors.initials: T
authors.lastname: Minematsu
authors.forename: Masanori
authors.initials: M
authors.lastname: Suzuki
authors.forename: Naoko
authors.initials: N
authors.lastname: Sanno
authors.forename: Susumu
authors.initials: S
authors.lastname: Takekoshi
authors.forename: Akira
authors.initials: A
authors.lastname: Teramoto
authors.forename: R Yoshiyuki
authors.initials: RY
authors.lastname: Osamura
mesh_terms: D000236:Adenoma / Q000098:blood supply / Q000378:metabolism* / Q000473:pathology; D017209:Apoptosis / Q000502:physiology; D049109:Cell Proliferation; D006801:Humans; D007150:Immunohistochemistry; D009363:Neoplasm Proteins / Q000096:biosynthesis*; D009389:Neovascularization, Pathologic / Q000378:metabolism*; D010911:Pituitary Neoplasms / Q000098:blood supply / Q000378:metabolism* / Q000473:pathology; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D064249:Securin; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
chemical_list: D009363:Neoplasm Proteins; D012333:RNA, Messenger; D064249:Securin; D042461:Vascular Endothelial Growth Factor A; C578002:pituitary tumor-transforming protein 1, human